| Quarter (USD) | Sep 25 | Jun 25 | Mar 25 | Dec 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 13.65 mm | 13.65 mm | 13.65 mm | 13.65 mm | 13.65 mm | 13.65 mm |
| Cash burn (monthly) | 1.42 mm | 1.15 mm | (no burn) | (no burn) | 1.24 mm | 836.00 k |
| Cash used (since last report) | 3.25 mm | 2.63 mm | n/a | n/a | 2.85 mm | 1.92 mm |
| Cash remaining | 10.40 mm | 11.02 mm | n/a | n/a | 10.79 mm | 11.73 mm |
| Runway (months of cash) | 7.3 | 9.6 | n/a | n/a | 8.7 | 14.0 |
| 13F holders | Current |
|---|---|
| Total holders | 47 |
| Opened positions | 8 |
| Closed positions | 7 |
| Increased positions | 12 |
| Reduced positions | 8 |
| 13F shares | Current |
|---|---|
| Total value | 7.47 bn |
| Total shares | 8.64 mm |
| Total puts | 5.30 k |
| Total calls | 40.90 k |
| Total put/call ratio | 0.1 |
| Largest owners | Shares | Value |
|---|---|---|
| Nacht Marius | 2.21 mm | $0.00 |
| Dexcel Pharma Technologies | 2.03 mm | $4.56 mm |
| Renaissance Technologies | 1.12 mm | $2.10 bn |
| NTRS Northern Trust | 731.74 k | $1.38 bn |
| Millennium Management | 387.92 k | $729.29 mm |
| Gsa Capital Partners | 305.75 k | $575.00 k |
| Stratos Wealth Partners | 270.00 k | $507.60 mm |
| BlackRock | 224.66 k | $422.35 mm |
| Bridgeway Capital Management | 181.40 k | $341.03 mm |
| MS Morgan Stanley | 170.22 k | $320.01 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 18 Nov 25 | Amos Bar-Shalev | Common Stock | Sell | Dispose S | No | No | 1.87 | 168 | 314.16 | 0 |
| 3 Sep 25 | Christian Elze | Common Stock | Grant | Acquire A | Yes | No | 0 | 7,500 | 0.00 | 7,500 |
| 3 Sep 25 | Christian Elze | Stock Options Common Stock | Grant | Acquire A | No | No | 1.64 | 15,000 | 24.60 k | 15,000 |
| 3 Sep 25 | Zvi Shmuel Ben | Common Stock | Grant | Acquire A | Yes | No | 0 | 7,500 | 0.00 | 7,500 |
| 3 Sep 25 | Zvi Shmuel Ben | Stock Options Common Stock | Grant | Acquire A | No | No | 1.64 | 15,000 | 24.60 k | 15,000 |
| 3 Sep 25 | Amos Bar-Shalev | Common Stock | Grant | Acquire A | Yes | No | 0 | 7,500 | 0.00 | 7,500 |
| 3 Sep 25 | Amos Bar-Shalev | Stock Options Common Stock | Grant | Acquire A | No | No | 1.64 | 15,000 | 24.60 k | 15,000 |
| 3 Sep 25 | Yaron Naos | Common Stock | Grant | Acquire A | Yes | No | 0 | 25,000 | 0.00 | 225,817 |
| 3 Sep 25 | Yaron Naos | Stock Option Common Stock | Grant | Acquire A | No | No | 1.64 | 50,000 | 82.00 k | 50,000 |
